We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$11.1B
AUM Growth
-$771M
Cap. Flow
-$1.01B
Cap. Flow %
-9.11%
Top 10 Hldgs %
9.6%
Holding
1,240
New
103
Increased
332
Reduced
508
Closed
87

Top Buys

Rank Stock Value
1
VRS
Verso Corporation
VRS
+$18.6M
2
DBI icon
Designer Brands
DBI
+$15.6M
3
GIII icon
G-III Apparel Group
GIII
+$14.6M
4
ARLP icon
Alliance Resource Partners
ARLP
+$14.4M
5
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
+$13M

Top Sells

Rank Stock Value
1
MDSO
Medidata Solutions, Inc.
MDSO
+$72.7M
2
CIR
CIRCOR International, Inc
CIR
+$40.1M
3
CRAY
Cray, Inc.
CRAY
+$26.5M
4
VSH icon
Vishay Intertechnology
VSH
+$23.6M
5
MAN icon
ManpowerGroup
MAN
+$23M

Sector Composition

Rank Sector Weight
1 Industrials 29.26%
2 Technology 17.08%
3 Financials 13.64%
4 Consumer Discretionary 12.84%
5 Materials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTTR icon
1051
Otter Tail
OTTR
$3.68B
$39K ﹤0.01%
739
-58
-7% -$2.95K
SGMA
1052
DELISTED
Sigmatron International
SGMA
$39K ﹤0.01%
15,373
-107,865
-88% -$284K
ARNA
1053
DELISTED
Arena Pharmaceuticals Inc
ARNA
$39K ﹤0.01%
+661
New +$34.2K
REGI
1054
DELISTED
Renewable Energy Group, Inc.
REGI
$39K ﹤0.01%
2,452
+740
+43% +$13.6K
FIZZ icon
1055
National Beverage
FIZZ
$2.98B
$38K ﹤0.01%
1,686
+216
+15% +$5.56K
NHC icon
1056
National Healthcare
NHC
$3.57B
$38K ﹤0.01%
472
-22
-4% -$1.7K
STR
1057
DELISTED
Sitio Royalties
STR
$38K ﹤0.01%
+1,136
New +$37.3K
HEES
1058
DELISTED
H&E Equipment Services
HEES
$37K ﹤0.01%
1,264
-66
-5% -$1.84K
LGND icon
1059
Ligand Pharmaceuticals
LGND
$5.59B
$37K ﹤0.01%
513
+32
+7% +$2.36K
SBH icon
1060
Sally Beauty Holdings
SBH
$1.5B
$37K ﹤0.01%
2,780
+270
+11% +$4.41K
SYKE
1061
DELISTED
SYKES Enterprises Inc
SYKE
$37K ﹤0.01%
+1,342
New +$36.1K
LBRT icon
1062
Liberty Energy
LBRT
$3.19B
$36K ﹤0.01%
2,208
+141
+7% +$2.16K
RVLP
1063
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$36K ﹤0.01%
+9,479
New +$31.5K
YELL
1064
DELISTED
Yellow Corporation Common Stock
YELL
$36K ﹤0.01%
8,834
+3,161
+56% +$18.3K
PAHC icon
1065
Phibro Animal Health
PAHC
$1.46B
$35K ﹤0.01%
1,110
+31
+3% +$972
USNA icon
1066
Usana Health Sciences
USNA
$282M
$35K ﹤0.01%
435
+54
+14% +$4.28K
CMD
1067
DELISTED
Cantel Medical Corporation
CMD
$35K ﹤0.01%
439
-9,093
-95% -$639K
ARA
1068
DELISTED
American Renal Associates Holdings, Inc
ARA
$35K ﹤0.01%
+4,671
New +$30.8K
USCR
1069
DELISTED
U S Concrete, Inc.
USCR
$34K ﹤0.01%
+691
New +$32.2K
LRN icon
1070
Stride
LRN
$3.44B
$33K ﹤0.01%
1,076
-6,008
-85% -$193K
SNBR
1071
DELISTED
Sleep Number
SNBR
$33K ﹤0.01%
+824
New +$31.8K
NUVA
1072
DELISTED
NuVasive, Inc.
NUVA
$33K ﹤0.01%
572
-106
-16% -$6.26K
BBSI icon
1073
Barrett Business Services
BBSI
$805M
$32K ﹤0.01%
1,536
-88
-5% -$1.7K
THFF icon
1074
First Financial Corp
THFF
$930M
$32K ﹤0.01%
+789
New +$31.8K
WW
1075
DELISTED
WW International
WW
$32K ﹤0.01%
1,663
-185
-10% -$3.67K
41 42
43
44 45

Similar funds

JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
LC
Loews Corp New York $12.5B AUM 4.69% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $12.6B AUM 11.86% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Royce & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Royce & Associates held 1,240 positions worth $11.1B, down 6.5% from $11.8B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates withdrew a net $1.01B in Q2 2019, closing 87 positions and reducing 508 holdings. Its most notable exit was Universal Corp, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in G-III Apparel Group worth $12.6M.

  • Royce & Associates's largest Q2 2019 buy was G-III Apparel Group: 426,975 shares worth $12.6M.
  • Royce & Associates added most to Verso Corporation in Q2 2019, an estimated $18.6M increase.
  • Royce & Associates's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $72.7M.
  • Royce & Associates fully exited Universal Corp in Q2 2019, selling an estimated $17.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $11.1B portfolio in Q2 2019.
  • Royce & Associates opened 103 new positions and closed 87 in Q2 2019.
  • Royce & Associates's portfolio value fell 6.5% quarter-over-quarter to $11.1B.

Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.